These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


205 related items for PubMed ID: 12651805

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prediction of phenotype for dextromethorphan O-demethylation by using polymerase chain reaction in healthy volunteers.
    Zimmermann T, Schlenk R, Pfaff G, Lach P, Wildfeuer A.
    Arzneimittelforschung; 1995 Jan; 45(1):41-3. PubMed ID: 7893267
    [Abstract] [Full Text] [Related]

  • 6. CYP2D6 genotype and phenotype determination in a Mexican Mestizo population.
    López M, Guerrero J, Jung-Cook H, Alonso ME.
    Eur J Clin Pharmacol; 2005 Nov; 61(10):749-54. PubMed ID: 16249913
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. CYP2D6 genotype and phenotyping by determination of dextromethorphan and metabolites in serum of healthy controls and of patients under psychotropic medication.
    Köhler D, Härtter S, Fuchs K, Sieghart W, Hiemke C.
    Pharmacogenetics; 1997 Dec; 7(6):453-61. PubMed ID: 9429230
    [Abstract] [Full Text] [Related]

  • 11. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences.
    Sachse C, Brockmöller J, Bauer S, Roots I.
    Am J Hum Genet; 1997 Feb; 60(2):284-95. PubMed ID: 9012401
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CYP2D6 polymorphism in a Gabonese population: contribution of the CYP2D6*2 and CYP2D6*17 alleles to the high prevalence of the intermediate metabolic phenotype.
    Panserat S, Sica L, Gérard N, Mathieu H, Jacqz-Aigrain E, Krishnamoorthy R.
    Br J Clin Pharmacol; 1999 Jan; 47(1):121-4. PubMed ID: 10073750
    [Abstract] [Full Text] [Related]

  • 18. CYP2D6 phenotyping with dextromethorphan.
    Wojtczak A, Rychlik-Sych M, Krochmalska-Ulacha E, Skretkowicz J.
    Pharmacol Rep; 2007 Jan; 59(6):734-8. PubMed ID: 18195464
    [Abstract] [Full Text] [Related]

  • 19. Determination of dextromethorphan metabolic phenotype by salivary analysis with a reference to genotype in Chinese patients receiving renal hemodialysis.
    Hou ZY, Chen CP, Yang WC, Lai MD, Buchert ET, Chung HM, Pickle LW, Woosley RL.
    Clin Pharmacol Ther; 1996 Apr; 59(4):411-7. PubMed ID: 8612385
    [Abstract] [Full Text] [Related]

  • 20. CYP2D6 genotype and dextromethorphan hydroxylation phenotype in an Ecuadorian population.
    Dorado P, Heras N, Machín E, Hernández F, Teran E, Llerena A.
    Eur J Clin Pharmacol; 2012 May; 68(5):637-44. PubMed ID: 22083166
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.